Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/13/2009 | CA2714042A1 Method for the targeted integration of multiple copies of a gene of interest in a yarrowia strain |
08/13/2009 | CA2713871A1 Sequences associated with tdp-43 proteinopathies and methods of using the same |
08/13/2009 | CA2713869A1 Directed evolution of grg31 and grg36 epsp synthase enzymes |
08/13/2009 | CA2713786A1 Anti trka antibodies and derivatives thereof |
08/13/2009 | CA2713582A1 Ts23 alpha-amylase variants with altered properties |
08/13/2009 | CA2713564A1 Method of producing lactic acid by continuous fermentation |
08/13/2009 | CA2713504A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
08/13/2009 | CA2713451A1 Variants of bacillus stearothermophilus alpha-amylase and uses thereof |
08/13/2009 | CA2713156A1 Methods of diagnosing and treating parp-mediated diseases |
08/13/2009 | CA2713138A1 Promoter, promoter control elements, and combinations, and uses thereof |
08/13/2009 | CA2712965A1 Antigen-binding polypeptides against cartilage degeneration |
08/13/2009 | CA2712606A1 Modified leptin polypeptides and their uses |
08/13/2009 | CA2712426A1 Paired end sequencing |
08/13/2009 | CA2711794A1 1d05 pcsk9 antagonists |
08/13/2009 | CA2711791A1 1b20 pcsk9 antagonists |
08/13/2009 | CA2709925A1 Leporipoxvirus-derived vaccine vectors |
08/13/2009 | CA2708280A1 Thermophilic and thermoacidophilic biopolymer-degrading genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods |
08/12/2009 | EP2088209A1 Methods for generating databases and databases for identifying polymorphic genetic markers |
08/12/2009 | EP2088202A1 Translation and synthesis of polypeptide having nonnative structure at n-terminus and application thereof |
08/12/2009 | EP2088201A1 Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells |
08/12/2009 | EP2088200A1 Manipulation of the phenolic acid content and digestibility of plant cell walls by targeted expression of genes encoding cell wall degrading enzymes |
08/12/2009 | EP2088199A1 A strain of genetically reengineered escherichia coli for biosynthesis of high yield carotenoids after mutation screening |
08/12/2009 | EP2088198A2 Transgenic systems for the manufacture of poly(3-hydroxy-butyrate-CO-3-hydroxyhexanoate) |
08/12/2009 | EP2088197A2 Haemophilus influenzae antigens and corresponding DNA fragments |
08/12/2009 | EP2088196A1 Methods and devices for producing biomolecules |
08/12/2009 | EP2088195A1 Recombinant vector for deleting specific regions of chromosome and method for deleting specific chromosomal regions of chromosome in the microorganism using the same |
08/12/2009 | EP2088194A1 Method for selecting hop line and breeding marker and primer set used for selecting hop line |
08/12/2009 | EP2088193A1 Novel shuttle vector |
08/12/2009 | EP2088192A1 Lytic enzyme inhibitor, lysis inhibitor, inhibitor of degradation of poly- gamma-glutamic acid, and method for production of poly- gamma-glutamic acid |
08/12/2009 | EP2088188A1 Direct expression of peptides into culture media |
08/12/2009 | EP2088159A1 Antibody recognizing c-domain of midkine |
08/12/2009 | EP2088158A2 Monoclonal antibody against the CCR5 chemokine receptor |
08/12/2009 | EP2087934A1 Method and device for processing a sample automatically |
08/12/2009 | EP2087912A1 ENVIRONMENT-RESPONDING siRNA CARRIER USING DISULFIDE-BRIDGED POLYMERIC MICELLE |
08/12/2009 | EP2087908A1 Antibodies to opgl |
08/12/2009 | EP2087906A1 Proteins expressed by Mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
08/12/2009 | EP2087789A1 Fto-modified non-human mammal |
08/12/2009 | EP2087129A2 Method for identifying modulators of the nrf2-keap1-are pathway |
08/12/2009 | EP2087125A1 Transgenic non-human animal |
08/12/2009 | EP2087124A2 Improved grg23 epsp synthases: compositions and methods of use |
08/12/2009 | EP2087123A2 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes |
08/12/2009 | EP2087122A1 Maize with good digestibility and disease resistant |
08/12/2009 | EP2087121A1 Maize with enhanced tolerance to fungal pathogens |
08/12/2009 | EP2087120A2 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
08/12/2009 | EP2087119A1 Insect inhibition by plant serpin |
08/12/2009 | EP2087118A1 A novel vector and expression cell line for mass production of recombinant protein and a process of producing recombinant protein using same |
08/12/2009 | EP2087117A1 New ketolases for the production of ketocarotenoids in tagetes |
08/12/2009 | EP2087116A1 Mutant ilv5 gene and use thereof |
08/12/2009 | EP2087115A2 Blocking of gene expression in eukaryotic cells |
08/12/2009 | EP2087111A2 Polypeptide variants |
08/12/2009 | EP2087108A1 Arabinose isomerase expressed from corynebacterium genus and tagatose manufacturing method by using it |
08/12/2009 | EP2087102A2 Enhancement of hybridoma fusion efficiencies through cell synchronization |
08/12/2009 | EP2087096A2 Modified cyanobacteria |
08/12/2009 | EP2087092A2 Electroporation cuvette with high field intensity and field-induced agitation |
08/12/2009 | EP2087005A2 Compounds |
08/12/2009 | EP2087002A2 Compositions and methods for binding sphingosine-1-phosphate |
08/12/2009 | EP2086998A1 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and use thereof |
08/12/2009 | EP2086590A2 Modulation of t cell signaling threshold and t cell sensitivity to antigens |
08/12/2009 | EP2086579A2 Poultry vaccine, for necrotic enteritis, comprising a mutated clostridium perfringens alpha toxin antigen, and methods of producing the vaccine |
08/12/2009 | EP2086534A1 Compounds, compositions and methods for controlling invertebrate pests |
08/12/2009 | EP1969146A4 Methods for nucleic acid mapping and identification of fine-structural-variations in nucleic acids and utilities |
08/12/2009 | EP1896588B1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF |
08/12/2009 | EP1893759B1 Methods for increasing the resistance of plants to hypoxic conditions |
08/12/2009 | EP1819729B8 Method for producing carboxy-terminal amidified peptides |
08/12/2009 | EP1794190B1 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
08/12/2009 | EP1782061A4 Method for redesign of microbial production systems |
08/12/2009 | EP1692271B1 Novel rumen bacteria variants and process for preparing succinic acid employing the same |
08/12/2009 | EP1687323A4 Methods and compositions for seamless cloning of nucleic acid molecules |
08/12/2009 | EP1675579B1 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
08/12/2009 | EP1562444B1 Process for reducing the acrylamide content of heat-treated foods |
08/12/2009 | EP1558727B1 Mutants for the preparation of d-amino acids |
08/12/2009 | EP1550672B1 Chimeric antagonist anth1 |
08/12/2009 | EP1546302B1 Methods for producing mammalian trypsins |
08/12/2009 | EP1514116B1 Oxaliplatin anti-resistance method |
08/12/2009 | EP1504104B1 Insect resistant plants and methods for making the same |
08/12/2009 | EP1465912B9 Chimeric tnf ligands |
08/12/2009 | EP1456223B1 Rapidly maturing fluorescent proteins and methods for using the same |
08/12/2009 | EP1424895B1 Method for expression of small antiviral rna molecules within a cell |
08/12/2009 | EP1416048B1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant |
08/12/2009 | EP1401376A4 Colloidal metal compositions and methods |
08/12/2009 | EP1385882B9 Peptides and related molecules that bind to tall-1 |
08/12/2009 | EP1373566B1 Polynucleotide analysis using combinatorial pcr |
08/12/2009 | EP1322957B1 Diagnostic markers of acute coronary syndromes and methods of use thereof |
08/12/2009 | EP1315839B9 Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations |
08/12/2009 | EP1299414B1 Fluorescent proteins |
08/12/2009 | EP1290227B1 Compositions, kits, and methods for identification and modulation of type i diabetes |
08/12/2009 | EP1259608B1 Modified fluorescent proteins |
08/12/2009 | EP1255813B1 Multipotent neural stem cells from mammalian skin and uses thereof |
08/12/2009 | EP1255780B1 Methods for generating human monoclonal antibodies |
08/12/2009 | EP1198589B9 Tenascin-c nucleic acid ligands |
08/12/2009 | EP1188823B1 Transformed microorganism and process for producing d-aminoacylase |
08/12/2009 | EP1187939B9 Detection of hiv-1 by nucleic acid amplification |
08/12/2009 | EP1141239B1 Improved methods for insertion of nucleic acids into circular vectors |
08/12/2009 | EP1137941B1 Protein scaffolds for antibody mimics and other binding proteins |
08/12/2009 | EP1127944B9 Methods for screening compounds inhibiting inflammatory cytokine production |
08/12/2009 | EP1090133B1 Production of il-10 in non-food crop plant bioreactor |
08/12/2009 | CN101506376A Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
08/12/2009 | CN101506370A Method and apparatus of low strengh electric field network-mediated delivery |
08/12/2009 | CN101506369A Vectors with modified initiation codon for the translation of AAV-REP78 useful for production of AAV in insect cells |
08/12/2009 | CN101506368A Transducible delivery of nucleic acids by reversible phosphotriester charge neutralization protecting groups |